China Pharma Holdings (CHPI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CHPI Annual Balance Sheets →
A period-by-period view of the balance sheet from China Pharma Holdings to Jun 30 2011 helps clarify how Jun 30 2012's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2012)
(Mar 31 2012) (Dec 31 2011) (Sep 30 2011) (Jun 30 2011)
Assets
Cash & cash equivalent3.54
Cash & Short-term Investments3.00
Accounts receivable2.20
Other Receivables, Net, Current0.00
Inventories0.21
Other Current Assets0.00
Income Taxes, Current0.28
Prepaid Expense And Other Assets Current0.00
Total Current Assets6.59
Equipment/Property/Plant Net2.08
Intangible Assets1.87
Other Assets, Noncurrent0.00
Total Assets9.75
Liabilities
Accounts Payable0.22
Accrued Liabilities, Current AC0.40
Notes Payable, Current NO0.00
Other Liabilities, Current0.00
Accrued Income Taxes, Current TA0.16
Deferred Revenue DE0.00
Total Current Liabilities1.94
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities1.94
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock0.80
Retained Earnings / Accumulated Deficit6.45
Accumulated Other Comprehensive Income0.51
Other Equity0.51
Common Stockholder's Equity7.81
Total Stockholder's Equity7.81
Liabilities & Stockholder's Equity9.75
4 historic quarters locked

Sign in to unlock the full China Pharma Holdings balance sheet history.

About CHPI Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.